EWTXEdgewise Therapeutics, Inc.同业对比
Edgewise Therapeutics, Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EWTX本股 | $4.1B#6 | — | 9.1x#6 | — | — | -25.4%#10 | — | -0.0%#3 | -50.9%#5 | — | 109.8%#4 | — |
| COGT | $5.4B#1 | — | 10.1x#7 | 685.0x#8 | -65.0%#9 | -28.6%#11 | -4235.3%#9 | -61.8%#11 | -84.3%#6 | — | — | — |
| ERAS | $5.1B#2 | — | 14.2x#8 | — | — | 23.0%#6 | — | -34.4%#9 | — | — | 516.4%#1 | — |
| AMRN | — | — | — | — | -6.5%#7 | 55.4%#4 | -23.5%#4 | -8.7%#5 | -16.9%#3 | — | -23.0%#9 | — |
| TVTX | $4.8B#3 | — | 210.4x#11 | 9.7x#2 | 110.5%#3 | 92.1%#1 | -12.8%#3 | -113.1%#12 | — | — | 43.3%#6 | — |
| GOSS | $4.4B#4 | — | — | 91.0x#7 | -57.7%#8 | -201.4%#12 | -352.2%#8 | — | — | — | -95.3%#11 | — |
| GPCR | $4.4B#5 | — | 3.2x#2 | — | — | -15.2%#9 | — | -10.4%#7 | — | — | -37.7%#10 | — |
| ARQT | $4.0B#7 | 145.5x#3 | 18.2x#9 | 10.7x#3 | 91.3%#4 | 88.5%#2 | -3.3%#2 | -7.3%#4 | -4.1%#2 | — | 29.3%#7 | — |
| TNGX | $3.9B#8 | — | 3.8x#4 | 62.7x#6 | 48.3%#5 | 22.0%#7 | -178.4%#6 | -9.9%#6 | — | — | 189.2%#2 | — |
| LQDA | $3.8B#9 | 30.1x#2 | 19.4x#10 | 23.9x#4 | 1031.2%#1 | 47.1%#5 | -32.5%#5 | -35.3%#10 | — | — | 67.1%#5 | — |
| ABCL | $3.7B#10 | — | 4.2x#5 | 49.7x#5 | 160.6%#2 | 10.1%#8 | -289.0%#7 | -16.3%#8 | -28.0%#4 | — | 127.1%#3 | — |
| PBLS | $3.6B#11 | — | 3.4x#3 | — | — | — | — | 0.0%#2 | — | — | — | — |
| ACAD | $3.5B#12 | 9.2x#1 | 2.7x#1 | 3.3x#1 | 11.9%#6 | 73.0%#3 | 9.8%#1 | 29.9%#1 | 11.4%#1 | — | -8.0%#8 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-04。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议